Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Boston Scientific Corp (BSX)  
$68.02 0.69 (1.02%) as of 4:30 Mon 4/22


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 1,430,000,000
Market Cap: 97.27(B)
Last Volume: 7,659,790 Avg Vol: 8,465,245
52 Week Range: $48.64 - $68.84
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  297
Guru Rank Value     : 4.1
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 86,763 367,796 891,893 1,852,495
Total Sell Value $5,815,387 $21,391,604 $49,075,093 $90,475,166
Total People Sold 6 8 11 13
Total Sell Transactions 9 19 36 69
End Date 2024-01-21 2023-10-20 2023-04-21 2022-04-21

   
Records found: 1851
  Page 8 of 75  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mirviss Jeffrey B. SVP&Pres, Periph Intervent   •       •      –    2013-11-08 4/A OE $6.31 $126,200 D/D 20,000 85,190     -
   Mario Ernest Director   •       •      –    2013-11-08 4 S $11.73 $239,857 I/I (20,445) 0     -
   Mario Ernest Director   •       •      –    2013-11-08 4 S $11.73 $1,351,503 D/D (115,200) 394,959     -
   Mirviss Jeffrey B. SVP&Pres, Periph Intervent   •       •      –    2013-11-08 4 S $11.87 $237,402 D/D (20,000) 45,190     -
   Mahoney Michael F President & CEO   •       •      –    2013-11-01 4 D $11.75 $1,894,899 D/D (161,268) 474,430     -
   Mahoney Michael F President & CEO   •       •      –    2013-11-01 4 OE $0.00 $0 D/D 341,669 635,698     -
   Fitzgerald Joseph Michael SVP & President, CRM   •       •      –    2013-11-01 4 S $11.69 $107,982 D/D (9,236) 83,955     -
   Ballinger Kevin J. SVP & Pres, Interven Cardio   •       •      –    2013-10-28 4 D $11.58 $10,098 D/D (872) 78,481     -
   Ballinger Kevin J. SVP & Pres, Interven Cardio   •       •      –    2013-10-28 4 OE $0.00 $0 D/D 2,594 79,353     -
   Capello Jeffrey D EVP & Chief Financial Officer   •       –      –    2013-08-29 4 S $10.67 $5,607,309 D/D (525,000) 147,447     -
   Capello Jeffrey D EVP & Chief Financial Officer   •       –      –    2013-08-29 4 OE $7.41 $3,519,750 D/D 475,000 535,909     -
   Fitzgerald Joseph Michael SVP & President, CRM   •       •      –    2013-08-16 4 S $11.02 $101,420 D/D (9,202) 93,191     -
   Ballinger Kevin J. SVP & Pres, Interven Cardio   •       –      –    2013-08-14 4 S $11.28 $430,630 D/D (38,171) 73,519     -
   Fitzgerald Joseph Michael SVP & President, CRM   •       •      –    2013-07-29 4 D $10.97 $24,573 D/D (2,240) 98,149     -
   Fitzgerald Joseph Michael SVP & President, CRM   •       •      –    2013-07-29 4 OE $0.00 $0 D/D 6,665 100,389     -
   Onuscheck John Michael SVP & President, EMEA   •       •      –    2013-07-29 4 D $10.97 $24,156 D/D (2,202) 73,793     -
   Onuscheck John Michael SVP & President, EMEA   •       •      –    2013-07-29 4 OE $0.00 $0 D/D 4,165 75,995     -
   Mirviss Jeffrey B. SVP&Pres, Periph Intervent   •       •      –    2013-07-28 4 D $10.96 $12,396 D/D (1,131) 65,190     -
   Mirviss Jeffrey B. SVP&Pres, Periph Intervent   •       •      –    2013-07-28 4 OE $0.00 $0 D/D 3,364 66,321     -
   Pierce David A SVP and President, Endoscopy   •       •      –    2013-07-28 4 D $10.96 $844 D/D (77) 25,600     -
   Pierce David A SVP and President, Endoscopy   •       •      –    2013-07-28 4 OE $0.00 $0 D/D 234 25,677     -
   Prange Karen SVP&Pres, Uro & Womens Health   •       •      –    2013-07-02 4 D $9.17 $77,321 D/D (8,432) 17,430     -
   Prange Karen SVP&Pres, Uro & Womens Health   •       •      –    2013-07-02 4 OE $0.00 $0 D/D 25,862 25,862     -
   Capello Jeffrey D EVP & Chief Financial Officer   •       •      –    2013-06-16 4 D $9.51 $59,980 D/D (6,307) 197,447     -
   Capello Jeffrey D EVP & Chief Financial Officer   •       •      –    2013-06-16 4 OE $0.00 $0 D/D 14,665 203,754     -
  1851 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 8 of 75
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us